[1]
I. P. Gupta, P. U. Shingade, and S. Bansal, “Revitalization of thiazolidinedione the optimum agents to be combined with SGLT 2 inhibitors to optimize glycemic control and reduce cardiovascular mortality: randomized control trial”, Int J Res Med Sci, vol. 11, no. 6, pp. 2010–2014, May 2023.